I completed my third treatment on Christmas Eve. I felt pretty good through the holiday weekend but started to fade a little by Sunday. The major side effect at this point is fatigue. As most of you know taking a nap doesn't always help, but still feels good. Despite the treatment we are on, we [...]
At the University of New Mexico School of Medicine in Albuquerque, New Mexico (SKS) the Department of Urology just completed a study that showed that dutasteride, the generic name for a dual 5alpha-reductase inhibitor made by GlaxoSmithKline and marketed under the name Avodart™ in the US and Avolve™ in Europe, when administered to men with [...]
FDA just approved th first gonsdotropin-releasing hormone (GnRH) drug for the treatment of Advanced Prostate Cancer. This newly approved gonadotropin-releasing hormone (GnRH) receptor antagonist demonstrates rapid, long-term suppression of testosterone. Ferring Pharmaceuticals, USA (FP) received approval from the U.S. Food and Drug Administration (FDA) for degarelix, (generic name) which is a new injectable gonadotropin-releasing hormone [...]
Many members of Congress see the potential of an increased investment in the NIH as part of the solution to our ailing economy. We prostate cancer survivors can glean additional benefits from an increase to NIH funding, in our fight against this terrible disease. The belief that making an increased economic investment in research through [...]
The U.S. Food and Drug Administration (FDA) has approved a new drug which provides relief of moderate to severe acute pain. This is great news for us, because, advanced prostate cancer often brings pain from mets and breaking bones. This newly approved drug, tapentadol hydrochloride, is delivered as an immediate-release oral tablet. It is a [...]